Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07360457
GLP1 Analogues and the Risk of Osteoarthritis
Sponsor: Beni-Suef University
View on ClinicalTrials.gov
Summary
Assessing the effects of GLP1 RA Vs SGLT2 Inhibitors vs. Standard of care in joint pain, physical function, stiffness, and improving Quality of Life for patients with type 2 diabetes.
Official title: Association of GLP1 Analogues and SGLT2 Inhibitors With the Risk of Osteoarthritis in Type 2 Diabetic Patients
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
OBSERVATIONAL
Enrollment
390
Start Date
2026-02-01
Completion Date
2027-03-01
Last Updated
2026-01-22
Healthy Volunteers
No
Conditions
Interventions
DRUG
GLP-1 analog
glucagon like peptide analogues
DRUG
SGLT2 inhibitor
sodium glucose transporter-2 inhibitors
DRUG
Antidiabetic
Standard of care